SCHEMBL24933007

SCHEMBL24933007

NC(=O)c1cc(-c2ccc(OCC(=O)O)cc2)c(C(F)(F)F)[nH]c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 1/20 0.44
PPARA Q07869 1/20 0.44
PTGDR2 Q9Y5Y4 4/20 0.42
MAP4K4 O95819 1/20 0.40
ACACA Q13085 1/20 0.39
HSD17B1 P14061 2/20 0.39
HSD17B2 P37059 2/20 0.39
AGER Q15109 1/20 0.38
ADORA2A P29274 2/20 0.38
ADORA2B P29275 2/20 0.38
PLA2G10 O15496 1/20 0.38
PLA2G2A P14555 1/20 0.38
PTPN1 P18031 2/20 0.38
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24933256 0.88 PDK2 (0.43) HSD17B1HSD17B2PRKAB2PRKAG1PRKAA2
SCHEMBL24933349 0.86 GSTP1 (0.50) HSD17B1HSD17B2
SCHEMBL24932956 0.85 FYN (0.45) PTGDR2HSD17B1HSD17B2
SCHEMBL24933847 0.84 CHEK1 (0.46) HSD17B1HSD17B2PRKAB2PRKAG1PRKAA2
SCHEMBL24933253 0.84 HSD17B2 (0.37) PTGDR2HSD17B1HSD17B2PRKAB2PRKAG1
SCHEMBL24933212 0.84 HSD17B1 (0.34) PPARDPPARAHSD17B1HSD17B2ADORA2A
SCHEMBL24933333 0.84 GSTP1 (0.44) HSD17B1HSD17B2
SCHEMBL24933053 0.83 KDM4E (0.44) PTGDR2HSD17B1HSD17B2PLA2G2ASMN1; SMN2
SCHEMBL24933671 0.83 MAOB (0.56) PPARDPPARAFFAR4
SCHEMBL24932950 0.81 HSD17B2 (0.52) HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed